Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2026-03-02 @ 6:24 PM
Study NCT ID:
NCT04526834
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-04-20
First Post:
2020-08-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma
Sponsor:
Tessa Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2036-03
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-20
First Submit QC Date:
None
Study First Post Date:
2020-08-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-18
Last Update Post Date:
2023-04-20
Last Update Post Date Type:
ACTUAL